(SBS) Companhia de Saneamento - Ratings and Ratios
Exchange: NYSE •
Country: Brazil •
Currency: USD •
Type: Common Stock •
ISIN: US20441A1025
Water, Sewage, Treatment, Connections
Dividends
| Dividend Yield | 2.44% |
| Yield on Cost 5y | 8.22% |
| Yield CAGR 5y | 2.76% |
| Payout Consistency | 72.2% |
| Payout Ratio | 42.4% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 28.9% |
| Value at Risk 5%th | 46.6% |
| Relative Tail Risk | -2.04% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.92 |
| Alpha | 75.14 |
| CAGR/Max DD | 1.67 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.440 |
| Beta | 0.450 |
| Beta Downside | 0.269 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.79% |
| Mean DD | 6.36% |
| Median DD | 5.24% |
Description: SBS Companhia de Saneamento October 30, 2025
Companhia de Saneamento Básico do Estado de São Paulo (SABESP, NYSE:SBS) is Brazil’s largest water-and-sewage utility, serving 9.5 million water connections and 8.2 million sewage connections across 375 municipalities in São Paulo State as of 31 Dec 2024.
Key recent metrics: • 2024 revenue of R$ 30.2 bn, up 3.5 % YoY, driven by modest tariff adjustments approved by the state regulator. • Adjusted EBITDA margin stabilized around 45 % after a 2023-24 capital-intensive expansion phase. • Net debt/EBITDA ratio sits at 2.1×, reflecting a disciplined refinancing program that extended maturities to 2029.
Primary economic and sector drivers: • Brazil’s inflation-linked tariff regime allows periodic water-price increases, which historically boost top-line growth in line with CPI (average 4.2 % YoY over the past five years). • Ongoing urbanization and population growth in São Paulo (≈ 12 million new residents projected by 2030) raise demand for both water supply and sewage treatment. • Government-mandated universal access targets spur capital-intensive projects, creating a pipeline of roughly R$ 15 bn in approved investments through 2027.
If you want a data-rich, scenario-based assessment of SABESP’s valuation and risk profile, the ValueRay platform provides a structured deep-dive that can help sharpen your investment thesis.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (8.03b TTM) > 0 and > 6% of Revenue (6% = 2.47b TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA -22.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.80% (prev 0.51%; Δ -5.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 10.12b > Net Income 8.03b (YES >=105%, WARN >=100%) |
| Net Debt (29.96b) to EBITDA (14.69b) ratio: 2.04 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (683.1m) change vs 12m ago -0.08% (target <= -2.0% for YES) |
| Gross Margin 35.31% (prev 54.67%; Δ -19.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 74.75% (prev 249.0%; Δ -174.2pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.76 (EBITDA TTM 14.69b / Interest Expense TTM 1.48b) >= 6 (WARN >= 3) |
Altman Z'' 2.90
| (A) -0.02 = (Total Current Assets 12.56b - Total Current Liabilities 14.53b) / Total Assets 95.99b |
| (B) 0.19 = Retained Earnings (Balance) 18.25b / Total Assets 95.99b |
| (C) 0.23 = EBIT TTM 12.93b / Avg Total Assets 55.14b |
| (D) 0.80 = Book Value of Equity 42.71b / Total Liabilities 53.28b |
| Total Rating: 2.90 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 76.31
| 1. Piotroski 5.50pt |
| 2. FCF Yield 8.67% |
| 3. FCF Margin 24.46% |
| 4. Debt/Equity 0.82 |
| 5. Debt/Ebitda 2.04 |
| 6. ROIC - WACC (= 6.36)% |
| 7. RoE 20.28% |
| 8. Rev. Trend 79.64% |
| 9. EPS Trend -46.93% |
What is the price of SBS shares?
As of December 05, 2025, the stock is trading at USD 26.88 with a total of 841,740 shares traded.
Over the past week, the price has changed by +1.93%, over one month by +8.69%, over three months by +19.89% and over the past year by +83.12%.
Over the past week, the price has changed by +1.93%, over one month by +8.69%, over three months by +19.89% and over the past year by +83.12%.
Is SBS a buy, sell or hold?
Companhia de Saneamento has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy SBS.
- Strong Buy: 3
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SBS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.5 | -1.6% |
| Analysts Target Price | 26.5 | -1.6% |
| ValueRay Target Price | 40 | 48.7% |
SBS Fundamental Data Overview November 24, 2025
Market Cap BRL = 92.94b (17.35b USD * 5.3575 USD.BRL)
P/E Trailing = 12.8283
P/E Forward = 13.4953
P/S = 0.5006
P/B = 2.1656
P/EG = 2.55
Beta = 0.153
Revenue TTM = 41.21b BRL
EBIT TTM = 12.93b BRL
EBITDA TTM = 14.69b BRL
Long Term Debt = 28.92b BRL (from longTermDebt, last quarter)
Short Term Debt = 5.78b BRL (from shortTermDebt, last quarter)
Debt = 34.93b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.96b BRL (from netDebt column, last quarter)
Enterprise Value = 116.22b BRL (92.94b + Debt 34.93b - CCE 11.65b)
Interest Coverage Ratio = 8.76 (Ebit TTM 12.93b / Interest Expense TTM 1.48b)
FCF Yield = 8.67% (FCF TTM 10.08b / Enterprise Value 116.22b)
FCF Margin = 24.46% (FCF TTM 10.08b / Revenue TTM 41.21b)
Net Margin = 19.50% (Net Income TTM 8.03b / Revenue TTM 41.21b)
Gross Margin = 35.31% ((Revenue TTM 41.21b - Cost of Revenue TTM 26.66b) / Revenue TTM)
Gross Margin QoQ = 31.77% (prev 41.82%)
Tobins Q-Ratio = 1.21 (Enterprise Value 116.22b / Total Assets 95.99b)
Interest Expense / Debt = 1.95% (Interest Expense 679.5m / Debt 34.93b)
Taxrate = 33.40% (1.08b / 3.24b)
NOPAT = 8.61b (EBIT 12.93b * (1 - 33.40%))
Current Ratio = 0.86 (Total Current Assets 12.56b / Total Current Liabilities 14.53b)
Debt / Equity = 0.82 (Debt 34.93b / totalStockholderEquity, last quarter 42.71b)
Debt / EBITDA = 2.04 (Net Debt 29.96b / EBITDA 14.69b)
Debt / FCF = 2.97 (Net Debt 29.96b / FCF TTM 10.08b)
Total Stockholder Equity = 39.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.37% (Net Income 8.03b / Total Assets 95.99b)
RoE = 20.28% (Net Income TTM 8.03b / Total Stockholder Equity 39.62b)
RoCE = 18.86% (EBIT 12.93b / Capital Employed (Equity 39.62b + L.T.Debt 28.92b))
RoIC = 12.29% (NOPAT 8.61b / Invested Capital 70.07b)
WACC = 5.93% (E(92.94b)/V(127.87b) * Re(7.67%) + D(34.93b)/V(127.87b) * Rd(1.95%) * (1-Tc(0.33)))
Discount Rate = 7.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -81.65 | Cagr: -0.03%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈7.94b ; Y1≈9.80b ; Y5≈16.71b
Fair Price DCF = 416.2 (DCF Value 284.27b / Shares Outstanding 683.0m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -46.93 | EPS CAGR: -20.12% | SUE: 0.15 | # QB: 0
Revenue Correlation: 79.64 | Revenue CAGR: 18.02% | SUE: 0.87 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.47 | Chg30d=-0.007 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.13 | Chg30d=+0.049 | Revisions Net=+1 | Growth EPS=+16.4% | Growth Revenue=+12.8%
P/E Trailing = 12.8283
P/E Forward = 13.4953
P/S = 0.5006
P/B = 2.1656
P/EG = 2.55
Beta = 0.153
Revenue TTM = 41.21b BRL
EBIT TTM = 12.93b BRL
EBITDA TTM = 14.69b BRL
Long Term Debt = 28.92b BRL (from longTermDebt, last quarter)
Short Term Debt = 5.78b BRL (from shortTermDebt, last quarter)
Debt = 34.93b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.96b BRL (from netDebt column, last quarter)
Enterprise Value = 116.22b BRL (92.94b + Debt 34.93b - CCE 11.65b)
Interest Coverage Ratio = 8.76 (Ebit TTM 12.93b / Interest Expense TTM 1.48b)
FCF Yield = 8.67% (FCF TTM 10.08b / Enterprise Value 116.22b)
FCF Margin = 24.46% (FCF TTM 10.08b / Revenue TTM 41.21b)
Net Margin = 19.50% (Net Income TTM 8.03b / Revenue TTM 41.21b)
Gross Margin = 35.31% ((Revenue TTM 41.21b - Cost of Revenue TTM 26.66b) / Revenue TTM)
Gross Margin QoQ = 31.77% (prev 41.82%)
Tobins Q-Ratio = 1.21 (Enterprise Value 116.22b / Total Assets 95.99b)
Interest Expense / Debt = 1.95% (Interest Expense 679.5m / Debt 34.93b)
Taxrate = 33.40% (1.08b / 3.24b)
NOPAT = 8.61b (EBIT 12.93b * (1 - 33.40%))
Current Ratio = 0.86 (Total Current Assets 12.56b / Total Current Liabilities 14.53b)
Debt / Equity = 0.82 (Debt 34.93b / totalStockholderEquity, last quarter 42.71b)
Debt / EBITDA = 2.04 (Net Debt 29.96b / EBITDA 14.69b)
Debt / FCF = 2.97 (Net Debt 29.96b / FCF TTM 10.08b)
Total Stockholder Equity = 39.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.37% (Net Income 8.03b / Total Assets 95.99b)
RoE = 20.28% (Net Income TTM 8.03b / Total Stockholder Equity 39.62b)
RoCE = 18.86% (EBIT 12.93b / Capital Employed (Equity 39.62b + L.T.Debt 28.92b))
RoIC = 12.29% (NOPAT 8.61b / Invested Capital 70.07b)
WACC = 5.93% (E(92.94b)/V(127.87b) * Re(7.67%) + D(34.93b)/V(127.87b) * Rd(1.95%) * (1-Tc(0.33)))
Discount Rate = 7.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -81.65 | Cagr: -0.03%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈7.94b ; Y1≈9.80b ; Y5≈16.71b
Fair Price DCF = 416.2 (DCF Value 284.27b / Shares Outstanding 683.0m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -46.93 | EPS CAGR: -20.12% | SUE: 0.15 | # QB: 0
Revenue Correlation: 79.64 | Revenue CAGR: 18.02% | SUE: 0.87 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.47 | Chg30d=-0.007 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.13 | Chg30d=+0.049 | Revisions Net=+1 | Growth EPS=+16.4% | Growth Revenue=+12.8%
Additional Sources for SBS Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle